Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jolivet

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Revue De Synthese|August 4, 2010
[Not Available]J Jolivet
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Biochemical and pharmacologic rationale for high-dose methotrexateJ Jolivet
Methods in Enzymology|January 1, 1997
Human 5,10-methenyltetrahydrofolate synthetaseJ Jolivet
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Role of leucovorin dosing and administration scheduleJ Jolivet
Bailliere'S Clinical Haematology|January 1, 1991
Methotrexate and leucovorin in malignant blood diseasesJ Jolivet
Revue De Synthese|August 10, 2010
Erratum to: Emergences de la philosophie au Moyen AgeM J Jolivet
Journal of the National Cancer Institute|August 2, 1989
Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparationsR Bertrand, J Jolivet
The Journal of Biological Chemistry|May 25, 1989
Methenyltetrahydrofolate synthetase prevents the inhibition of phosphoribosyl 5-aminoimidazole 4-carboxamide ribonucleotide formyltransferase by 5-formyltetrahydrofolate polyglutamatesR Bertrand, J Jolivet
Advances in Experimental Medicine and Biology|January 1, 1993
Cellular interactions between the natural and unnatural isomers of 5-formyltetrahydrofolateJ Jolivet, R Bertrand
Advances in Experimental Medicine and Biology|January 1, 1988
The natural and unnatural diastereomers of leucovorin: aspects of their cellular pharmacologyR Bertrand, J Jolivet
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Revue De Synthese|August 4, 2010
[Not Available]J Jolivet
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Biochemical and pharmacologic rationale for high-dose methotrexateJ Jolivet
Methods in Enzymology|January 1, 1997
Human 5,10-methenyltetrahydrofolate synthetaseJ Jolivet
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Role of leucovorin dosing and administration scheduleJ Jolivet
Bailliere'S Clinical Haematology|January 1, 1991
Methotrexate and leucovorin in malignant blood diseasesJ Jolivet
Revue De Synthese|August 10, 2010
Erratum to: Emergences de la philosophie au Moyen AgeM J Jolivet
Journal of the National Cancer Institute|August 2, 1989
Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparationsR Bertrand, J Jolivet
The Journal of Biological Chemistry|May 25, 1989
Methenyltetrahydrofolate synthetase prevents the inhibition of phosphoribosyl 5-aminoimidazole 4-carboxamide ribonucleotide formyltransferase by 5-formyltetrahydrofolate polyglutamatesR Bertrand, J Jolivet
Advances in Experimental Medicine and Biology|January 1, 1993
Cellular interactions between the natural and unnatural isomers of 5-formyltetrahydrofolateJ Jolivet, R Bertrand
Advances in Experimental Medicine and Biology|January 1, 1988
The natural and unnatural diastereomers of leucovorin: aspects of their cellular pharmacologyR Bertrand, J Jolivet
Pageof 7